Search results
FDA faces backlash over approval of genetic test for opioid addiction risk
NBC Universal via AOL· 2 weeks agoThe Food and Drug Administration is facing backlash over its approval of a genetic test intended to...
Clinicians Slam FDA Over Approval of Opioid Addiction Test
Medscape· 2 weeks agoA group of researchers urged US regulators to revoke the approval of a test marketed for predicting...
Scientists urge FDA to rescind approval of test for opioid addiction risk
Washington Post via Yahoo News· 2 weeks agoIn a letter sent to the agency on Thursday, 31 experts in genetics, addiction, psychiatry and...
Experts Urge FDA, CMS to Revoke Approval, Coverage for Opioid Addiction Genetic Risk Test
GenomeWeb News· 2 weeks agoThis story has been updated to include statements from Solvd Health and the FDA. NEW YORK – A coalition of geneticists, addiction experts ...
Additional opioid overdose reversal drug, Opvee, helps in fight against opioid crisis
KATV Little Rock· 14 hours agoThe drug is called Opvee and was approved by the FDA in May of 2023 and is the first Nalmefene nasal spray to be approved. From 2019 ...
Analysis | As Republicans wrestle with IVF, the Biden administration expands benefits
Washington Post· 2 weeks agoToday’s edition: Scientists are urging federal regulators to rescind approval of a test for opioid ...
Small gift cards can be a key tool to stop stimulant addiction, but stigma stands in the way
CNN.com· 2 days agoClyde Davis battled a methamphetamine and heroin addiction for over nine years. Then three years...
Nayzilam: Mild to serious side effects and how to manage them
Medical News Today· 2 weeks agoAs with other drugs, Nayzilam can cause side effects, such as drowsiness, headache, and runny nose....
Health - The Washington Post
Washington Post· 2 weeks agoScientists urge FDA to rescind approval of test for opioid addiction riskRegulators authorized AvertD against the backdrop of the crushing ...
Q&A: Can weight loss drugs help in addiction treatment?
Medical Xpress· 6 days agoWhile this new class of drugs, called GLP-1 receptor agonist drugs, are approved for use in diabetes...
